Underwood Capital Limited has released a press release.
PTL completes Phase 2 clinical trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
- Appendix 4C
- Investment in Embark Health
- United Greeneries MOU to Supply Recreational Cannabis
- Investment in MediPharm Labs Inc
- Weed Me Secures Partnership with Dutch Passion
Later from Underwood Capital
- MediPharm signs customer contracts ahead of TSX-V listing
- OCS supply agreements for MMJ investee companies
- Postponement of General Meeting
- Prospectus
- Update on the PTL Disposal
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital